Biomarx
PrivateLast Round
Pre Seed
Jan 5, 2026
Total Funding Raised
$948,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biomarx is a medtech company that provides a platform for rapid, reliable, and affordable molecular diagnostic solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomarx Comparables
Compare Biomarx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QuantuMDx | 76% | |
| FluxErgy | 74% | |
| genedrive plc | 71% |
Biomarx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jan 5, 2026 | ||||
| Seed | Oct 13, 2025 |
Biomarx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Clarendon Fund Managers | Pre Seed |
| University of Strathclyde | Pre Seed |
| Techstart Ventures | Pre Seed |
| SFC Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
$948K round led by SFC Capital and Clarendon Fund Managers.
Biomarx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biomarx's valuation, stock price, and market status.
Is Biomarx a public or private company?
Biomarx is a private company.
What is the current stock price of Biomarx?
Biomarx is a private company with no public stock price. Caplight tracks Biomarx's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Biomarx worth (valuation)?
Valuation information for Biomarx is not publicly available.
Can I buy Biomarx stock?
Biomarx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biomarx's last funding round?
Biomarx's most recent funding round was Pre Seed on January 5, 2026.
Who are the main investors in Biomarx?
Key investors in Biomarx include Clarendon Fund Managers, SFC Capital.
Will Biomarx IPO soon?
No public IPO plans have been announced for Biomarx.
How can I track Biomarx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biomarx's secondary market activity and sign up for updates.